<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127696">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01835275</url>
  </required_header>
  <id_info>
    <org_study_id>2012P000969</org_study_id>
    <nct_id>NCT01835275</nct_id>
  </id_info>
  <brief_title>Audio-enhanced Analgesia in Healthy Subjects</brief_title>
  <official_title>Audio-enhanced Analgesia in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether enhanced audio methods can be used to
      improve analgesia for experimental pain in healthy subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Pain Intensity and Unpleasantness</measure>
    <time_frame>1.5 hour testing session</time_frame>
    <safety_issue>No</safety_issue>
    <description>0-100 Visual Analog Scales to rate subjective pain intensity and unpleasentness</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Music conditioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects are tested with music, sound, and silence, after conditioning to enhance music induced analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sound</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects are tested with music, sound, and silence, after conditioning to enhance sound induced analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Calibration</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects are tested with music, sound, and silence, with no enhanced audio received</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enhanced Audio</intervention_name>
    <arm_group_label>Music conditioning</arm_group_label>
    <arm_group_label>Sound</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Audio</intervention_name>
    <arm_group_label>Music conditioning</arm_group_label>
    <arm_group_label>Sound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-50 years old

          -  Healthy

        Exclusion Criteria:

          -  Current diagnoses of psychiatric or neurological disorders or chronic pain

          -  BDI-II score greater than 13

          -  current or previous ear/nose/throat or hearing issues

          -  prior participation in pain studies

          -  previous advanced music training
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Psychiatry, Mass General Hospital</name>
      <address>
        <city>Charlestown</city>
        <state>Massachusetts</state>
        <zip>02129</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 16, 2013</lastchanged_date>
  <firstreceived_date>March 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Randy L. Gollub</investigator_full_name>
    <investigator_title>Associate Professor, MD PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
